IMD Companies Inc (PK)【ICBU】株式ニュース

$ICBU Expands into the Non-Prescription Supplement Market
https://allcapresearch.com/f/icbu-expands-into-the-non-prescription-supplement-market

A New Chapter in Health and Wellness Innovation
iMD Companies, Inc. (OTC: ICBU), a Florida-based corporation, has repositioned itself with a clear focus on the health infusion technology market. With an emphasis on acquiring and developing cutting-edge health products, iMD seeks to leverage the expertise of its team members and subsidiaries to establish a significant presence in this growing industry.

The company’s latest strategic move—its acquisition of Riize LLC—marks a transformative step forward. Riize LLC, now operating under the name RiizeHealth.com, has already made waves in the telemedicine industry with its online prescription offerings for sexual health, weight control, and hair loss. Through its proprietary oral dissolving film strip technology, Riize has seen an impressive sixfold increase in sales order volume within its first year. This success has set the stage for its next venture: the over-the-counter supplement market.

Revolutionizing Healthcare with Telemedicine
Riize LLC is not just another telemedicine provider—it is revolutionizing the healthcare industry through its cutting-edge telemedicine and pharmacy services. Specializing in men's and women's sexual health and weight loss, Riize sets itself apart with its innovative delivery system, making healthcare more accessible and efficient than ever before.

Through Riize’s user-friendly online platform, patients can connect with licensed healthcare providers remotely, bypassing long wait times and eliminating the need for in-person clinic visits. Whether through video or phone consultations, individuals can discuss their symptoms, receive accurate diagnoses, and obtain personalized treatment plans tailored to their specific needs.

Riize’s commitment to breaking down barriers to healthcare access ensures that quality healthcare is just a few clicks away. By integrating its expertise in telemedicine with its upcoming expansion into non-prescription supplements, Riize is poised to reshape the future of digital healthcare.

Expansion into Non-Prescription Supplements
On December 16, 2024, iMD Companies and Riize LLC announced an ambitious expansion into the non-prescription supplement market, revealing a product launch timeline set for the first quarter of 2025. The company will introduce three new supplement products—Riize Energy, Riize Sleep, and Riize Xtra—through a dedicated e-commerce platform, RiizeUp.com. This move capitalizes on the booming supplement industry, where demand for natural health solutions continues to rise.

Each of these new products is tailored to address some of the fastest-growing consumer health concerns:

Riize Energy: Designed to enhance endurance, mental focus, and overall energy levels.
Riize Sleep: Formulated to promote relaxation and support healthy, restful sleep.
Riize Xtra: Crafted to boost circulation, testosterone production, stamina, and sexual vitality.

With projected compound annual growth rates (CAGRs) ranging from 6% to 10% in the coming years, the supplement market presents a lucrative opportunity for iMD and Riize. The company’s proprietary oral dissolving strip technology offers a unique competitive edge, ensuring superior bioavailability compared to traditional supplement forms.

Cutting-Edge Delivery System
What sets Riize’s supplement products apart from competitors is their rapid-dissolving oral strip technology. Unlike traditional pills and capsules that have bioavailability rates of just 10-30%, Riize’s strips achieve 90% absorption, allowing active ingredients to enter the bloodstream 6 to 9 times faster. This innovation enhances the efficacy of supplements, delivering fast-acting results for consumers seeking immediate benefits.

Additionally, the strips are vegan-friendly, sugar-free, and naturally flavored, making them an appealing choice for health-conscious individuals. By prioritizing convenience, efficiency, and quality, Riize is poised to disrupt the supplement industry.

Executive Insights and Growth Strategy
Reilly Schueler, CEO of Riize LLC, emphasized the significance of this expansion, stating:

“Our success in the telemedicine space has shown us the potential for growth in consumer wellness products. With these new non-prescription medicine supplements, we are bringing the same cutting-edge oral strip technology to the market, offering consumers a fast, effective, and innovative supplement experience. We believe this expansion into the non-prescription medicine space will drive significant growth for Riize and strengthen our brand's leadership in health and wellness.”

Rick Wilson, President and CEO of iMD Companies, Inc., echoed this sentiment:

“We are incredibly proud of what Riize LLC has achieved in such a short period. The combination of their innovative technology and consumer-focused products positions them perfectly for success in the rapidly growing non-prescription medicine market. This move represents a tremendous growth opportunity for both Riize and ICBU, and we look forward to seeing this new chapter unfold.”

Market Outlook and Investor Potential
The health and wellness industry has witnessed exponential growth in recent years, driven by increasing consumer interest in natural remedies, preventive healthcare, and accessible wellness solutions. According to market research, the global dietary supplements industry is projected to reach over $230 billion by 2027, reflecting a steady CAGR of 6-10%. With Riize’s innovative approach and iMD’s strategic leadership, the company is well-positioned to capitalize on this growth trajectory.

From an investment standpoint, iMD Companies’ expansion signals strong revenue potential and long-term value creation. By combining Riize’s success in telemedicine with its foray into non-prescription supplements, iMD is establishing a diversified portfolio that mitigates risk while enhancing its market reach.

Furthermore, the direct-to-consumer (DTC) model via RiizeUp.com allows the company to maximize profit margins while maintaining control over brand messaging and customer engagement. This strategy aligns with broader industry trends, where e-commerce has become a dominant force in supplement sales.

The Road Ahead
iMD Companies and Riize LLC’s latest expansion represents a pivotal moment in their evolution. With the official product launch scheduled for early 2025, the company is poised to make an immediate impact on the non-prescription supplement industry. Consumers can look forward to fast-acting, high-quality supplements, while investors can anticipate sustained growth and increased shareholder value.

As iMD continues to innovate and expand, its commitment to delivering cutting-edge health solutions remains steadfast. The combination of advanced oral dissolving film technology, consumer demand for effective wellness products, and a robust growth strategy positions iMD and Riize as emerging leaders in the space.

With a solid foundation, strategic vision, and an expanding product line, iMD Companies, Inc. is set to redefine health supplementation in 2025 and beyond.

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター